Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 334 followers
Latest posts
Last updated about 1 hour ago
FDA’s Vinay Prasad to depart agency at the end of April
about 1 hour ago
After a tumultuous tenure marked by recent clashes with the biopharma industry...
FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap
about 8 hours ago
The FDA is ending a roughly eight-month hiatus of drug-related advisory committee...
Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda
about 9 hours ago
Servier on Friday unveiled a deal to acquire Day One Biopharmaceuticals—a commercial-stage...
Chutes & Ladders—Bavarian Nordic CEO exits on heels of failed takeover
about 10 hours ago
After 27 years with Bavarian Nordic, including 12 as CEO, Paul Chaplin...
Beam rejigs deal to retain base editing technology amid partner's dissolution
about 11 hours ago
The planned closure of Bio Palette has triggered the termination of a...
Medtronic extends and expands long-term partnership with GE HealthCare
about 11 hours ago
Medtronic and GE HealthCare inked a multiyear deal to expand their more...
Cognito reaps $105M in series C funding for its Alzheimer's device
about 11 hours ago
Cognito Therapeutics, which is in late-stage development of its device to treat...
Setting a new bar? Zealand touts ‘placebo-like tolerability’ for Roche-partnered weight loss drug
1 day ago
Zealand Pharma’s Roche-partnered amylin analogue demonstrated “placebo-like tolerability” and up to 10.7%...
Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
1 day ago
Merck KGaA is no longer pursuing clinical-stage candidates obtained through its $3.9...
Senior FDA official refutes uniQure’s claims amid controversy over Huntington’s gene therapy
1 day ago
In a strikingly blunt briefing, a senior FDA official accused uniQure of...
Why early developability assessment is a strategic necessity in modern antibody discovery
1 day ago
As antibody discovery pipelines scale, early developability assessment is increasingly used to...
Alltrna undergoes third layoff round before entering clinic, cutting 35% of jobs
1 day ago
Flagship Pioneering-backed Alltrna is once again laying off staff, this time reducing...